Russian Journal of Woman and Child Health
ISSN 2618-8430 (Print), 2686-7184 (Online)

Cervical vaginal mixed infections in gynecology: unresolved therapeutic issues

VAK

Scopus

E-libraryDOAJ

russian citation indexroad

ebscoULRICHS

cyberleninkagoogle-scholar

ВИНИТИРГБ

Open accessCrossrefAntiplagiat

RMJ.ru

License Creative Commons
All papers are licensed under a Creative Commons «Attribution» 4.0 License.


Impact factor - 1,090*

* Impact factor according to the SCIENCE INDEX 2022

DOI: 10.32364/2618-8430-2019-2-3-194-199

K.R. Bondarenko

Pirogov Russian National Research Medical University, Moscow, Russian Federation

Significant progress in molecular biology since the early 2000s has improved our knowledge of cervical vaginal infections greatly. The paper covers important and unresolved issues on the diagnosis, treatment, and prevention of mixed infections of female reproductive system in outpatient gynecological practice in Russia. Pharmacotherapy regimens for bacterial vaginosis and vaginal candidiasis approved by Russian, US, and European clinical protocols are compared. Advantages and disadvantages of various treatment approaches to the most common variant of mixed infection (bacterial vaginosis and vaginal candidiasis) are discussed. Safety and efficacy of various drugs are compared on the basis of fundamental and clinical data accumulated over the last two decades. Suppositories with metronidazole (500 mg) and miconazole (100 mg) for 7 days are recommended as the first-line drug of choice for bacterial vaginosis and vaginal candidiasis.

Keywords: mixed infections, bacterial vaginosis, vaginal candidiasis, miconazole, metronidazole, Metromicon-Neo.

For citation: Bondarenko K.R. Cervical vaginal mixed infections in gynecology: unresolved therapeutic issues. Russian Journal of Woman and Child Health. 2019;2(3):–199.




About the author:

Karina R. Bondarenko — MD, PhD, Assistant Professor of the Department of Obstetrics and Gynecology, ORCID iD 0000-0003-4147-1151.

Pirogov Russian National Research Medical University. 1, Ostrovityanov str., Moscow, 117437, Russian Federation.

Contact information: Karina R. Bondarenko, e-mail: karinabond@mail.ru. Financial Disclosure: author has no financial or property interest in any material or method mentioned. There is no conflict of interests. Received 15.07.2019.




References
1. McClelland R., Balkus J.E., Lee J. et al. Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women. J Infect Dis. 2015;211(12):1875–1882. DOI: 10.1093/infdis/jiu818.
2. Peixoto F., Camargos A., Duarte G. et al. Efficacy and tolerance of metronidazole and miconazole nitrate in treatment of vaginitis. Int J Gynaecol Obstet. 2008;102:287–292. DOI: 10.1016/j.ijgo.2008.04.014.
3. Kenyon C., Colebunders R., Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol. 2013;209(6):505–523. DOI: 10.1016/j.ajog.2013.05.006.
4. Sobel J.D. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214:15–21. DOI: 10.1016/j.ajog.2015.06.067.
5. Liang Q., Li N., Song S. et al. High‐dose nifuratel for simple and mixed aerobic vaginitis: A single‐centre prospective open‐label cohort study. J Obstet Gynaecol Res. 2016;42(10):1354‐1360. DOI: 10,1111/jog.130524.
6. Sobel J.D., Subramanian C., Foxman B. et al. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013;15(2):104–108. DOI: 10.1007/s11908-013-0325-5.
7. Horner P., Donders G., Cusini M. et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? — a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018; 32 (11):1845–1851. DOI: 10.1111/jdv.15146.
8. Ehrström S., Kornfeld D., Rylander E. Perceived stress in women with recurrent vulvovaginal candidiasis. J Psychosom Obstet Gynaecol. 2007;28(3):169–176. DOI: 10,1080 / 01674820601168176.
9. Brotman R.M., Klebanoff M.A., Nansel T.R. et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance toincident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202(12):1907–1915. DOI: 10.1086/657320.
10. Atashili J., Poole C., Ndumbe P.M. et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493–1501. DOI: 10.1097/QAD.0b013e3283021a37.
11. Эпидемическая ситуация по ВИЧ-инфекции в России. (Электронный ресурс). URL: http://old.mednet.ru/images/stories/files/miac/2017_vich.pdf. Дата обращения: 24.06.2019. [The HIV epidemic in Russia. (Electronic resource). URL: http://old.mednet.ru/images/stories/files/miac/2017_vich.pdf. Access date: 06.24.2019 (in Russ.)].
12. Gillet E., Meys J.F., Verstraelen H. et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS One. 2012;7(10):e45201. DOI: 10.1371/journal.pone.0045201.
13. Taylor B.D., Darville T., Haggerty C.L. Does bacterial vaginosis cause pelvic inflammatory disease? Sex Transm Dis. 2013;40(2):117–122. DOI: 10.1097/OLQ.0b013e31827c5a5b.
14. CDC Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;64(3):69–77.
15. Доброхотова Ю.Э., Бондаренко К.Р., Гущин А.Е. и др. Результаты исследования цервико-вагинальной микробиоты методом ПЦР в реальном времени у беременных с угрожающими преждевременными родами. Акушерство и гинекология. 2018;11:50–59. DOI: 10.18565/aig.2018.11.50-59. [Dobrokhotova Yu.E., Bondarenko K.R., Gushchin A.E. et al. Results of a study of cervico-vaginal microbiota by real-time PCR in pregnant women with menacing premature births. Akusherstvo i ginekologiya. 2018;11:50–59 (in Russ.)]. DOI: 10.18565/aig.2018.11.50-59.
16. Sangkomkamhang U.S., Lumbiganon P., Prasertcharoensuk W., Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2015;2: Cd006178. DOI: 10,1002 / 14651858.CD006178.pub3.
17. Мавзютов А.Р., Бондаренко К.Р., Бондаренко В.М. Бактериальный вагиноз: этиопатогенетические аспекты. Журнал микробиологии, эпидемиологии и иммунобиологии. 2007;6:93–100. [Mavzyutov A.R., Bondarenko K.R., Bondarenko V.M. Bacterial vaginosis: etiopathogenetic aspects. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2007;6:93–100 (in Russ.)].
18. Fredricks D.N., Fiedler T.L., Thomas K.K. et al. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol. 2007;45:3270–3276. DOI:10.1128/jcm.01272–07.387.
19. Schwebke J.R., Muzny C.A., Josey W.E. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis. 2014;210:338–343. DOI: 10.1093/infdis/jiu089.
20. Mitchell C., Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol. 2014;71(6):555–563. DOI: 10.1111/aji.12264.
21. Swidsinski A., Mendling W., Loening-Baucke V. et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106:1013–1023. DOI: 10.1097/01.AOG.0000183594.45524.d2.
22. Muzny C.A., Schwebke J.R. Gardnerella vaginalis: Still a Prime Suspect in the Pathogenesis of Bacterial Vaginosis. Curr Infect Dis Rep. 2013;15(2):130–135. DOI: 10.1007/s11908-013-0318-4.
23. Patterson J.L., Girerd P.H., Karjane N.W., Jefferson K.K. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007;197(2):170.e1–170.e1707. DOI: 10.1016/j.ajog.2007.02.027.
24. Swidsinski A., Mendling W., Loening‐Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97.e1–6. DOI: 10,1016/j.ajog.2007.06.039.
25. Gonçalves C.S., Morton A.N., Hocking J. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193:1478. DOI: 10.1086/503780.
26. Gonçalves B., Ferreira C., Alves C.T. et al. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors 2016;42(6):905–927. DOI: 10.3109/1040841X.2015.1091805.
27. Swidsinski A., Guschin A., Tang Q. et al. Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. Am J Obstet Gynecol. 2019;220(1):91.e1–91.e8. DOI: 10.1016/j.ajog.2018.10.023.
28. Sobel J.D. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–1971. DOI: 10.1016/S0140-6736 (07) 60917-9.
29. Rivers C.A., Adaramola O.O., Schwebke J.R. Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern american STD clinic. Sex Transm Dis. 2011;38:672–674. DOI: 10.1097/OLQ.0b013e31820fc3b8.
30. Sherrard J., Wilson J., Donders G. et al. European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258–1272. DOI: 10.1177/0956462418785451.
31. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей. М.; 2019. [Clinical recommendations for the diagnosis and treatment of diseases accompanied by pathological discharge from the genital tract. M.; 2019 (in Russ.)].
32. Beigi R.H., Austin M.N., Meyn L.A. et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol. 2004;191:1124–1129. DOI: 10.1016/j.ajog.2004.05.033.
33. Aroutcheva A., Simoes J.A., Shott S., Faro S. The inhibitory effect of clindamycin on Lactobacillus in vitro. Infect Dis Obstet Gynecol. 2001;9(4):239–244. DOI: 10.1155/S1064744901000394.
34. Sobel J.D., Ferris D., Schwebke J. et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283–1289. DOI: 10.1016/j.ajog.2005.11.041.
35. Bradshaw C.S., Vodstrcil L.A., Hocking J.S. et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis. 2013;56:777–786. DOI: 10.1093/cid/cis1030.
36. Taylor-Robinson D., Lamont R.F. Mycoplasmas in pregnancy. BJOG. 2010;118:164–174. DOI: 10.1111/j.1471-0528.2010.02766.x.
37. Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res Microbiol. 2017;168:875–881. DOI: 10.1016/j.resmic.2017.02.009.
38. Ozyurt E., Toykuliyeva M.B., Danilyans I.L. et al. Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran) — a triple-activepessary for the treatment of single and mixed vaginal infections. Int J Gynaecol Obstet. 2001;74(1):35–43. DOI: 10.1016/S0020-7292(01)00388-5.



License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous paper
Next paper

Register now and get access to useful services:
  • Загрузка полнотекстовых версий журналов (PDF)
  • Медицинские калькуляторы
  • Список избранных статей по Вашей специальности
  • Видеоконференции и многое другое

С нами уже 50 000 врачей из различных областей.
Присоединяйтесь!
[Error] 
Call to undefined function get_registration_form_description_popup() (0)
/home/c/cb72209/wchjournal/public_html/en/include/reg_form.php:89
#0: include
	/home/c/cb72209/wchjournal/public_html/bitrix/modules/main/classes/general/main.php:1419
#1: CAllMain->IncludeFile(string)
	/home/c/cb72209/wchjournal/public_html/local/templates/.default/include/cl-footer.php:217
#2: include_once(string)
	/home/c/cb72209/wchjournal/public_html/local/templates/cl_inner_sidebar_en/footer.php:11
#3: include_once(string)
	/home/c/cb72209/wchjournal/public_html/bitrix/modules/main/include/epilog_before.php:93
#4: require(string)
	/home/c/cb72209/wchjournal/public_html/bitrix/modules/main/include/epilog.php:2
#5: require_once(string)
	/home/c/cb72209/wchjournal/public_html/bitrix/footer.php:4
#6: require(string)
	/home/c/cb72209/wchjournal/public_html/en/articles/index.php:150
#7: include_once(string)
	/home/c/cb72209/wchjournal/public_html/bitrix/modules/main/include/urlrewrite.php:184
#8: include_once(string)
	/home/c/cb72209/wchjournal/public_html/bitrix/urlrewrite.php:2
----------